These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10483287)

  • 1. [Controversial aspects regarding metformin in type 2 diabetic patient: reduction of late complications in early, single drug administration; increased risk of death in later administration in combination with sulfonylurea compounds].
    Ritzmann P
    Praxis (Bern 1994); 1999 Aug; 88(33):1330-1. PubMed ID: 10483287
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study.
    Sillars B; Davis WA; Hirsch IB; Davis TM
    Diabetes Obes Metab; 2010 Sep; 12(9):757-65. PubMed ID: 20649627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study.
    Gulliford M; Latinovic R
    Diabetes Metab Res Rev; 2004; 20(3):239-45. PubMed ID: 15133756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy.
    Johannes CB; Koro CE; Quinn SG; Cutone JA; Seeger JD
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):504-12. PubMed ID: 17245800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Don't throw the baby out with the bath water: mortality with combination metformin and sulfonylurea.
    Tayek JA
    Diabetes Metab Res Rev; 2007 Feb; 23(2):85-6. PubMed ID: 17262894
    [No Abstract]   [Full Text] [Related]  

  • 6. A comment on 'the risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy'.
    Chang Y; Choi NK; Hahn S; Park BJ
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1072-3; author reply 1073-4. PubMed ID: 17907252
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy and safety of glimepiride plus metformin in a single presentation, as combined therapy, in patients with type 2 diabetes mellitus and secondary failure to glibenclamide, as monotherapy].
    González-Ortiz M; Martínez-Abundis E;
    Rev Invest Clin; 2004; 56(3):327-33. PubMed ID: 15612515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy.
    McAlister FA; Eurich DT; Majumdar SR; Johnson JA
    Eur J Heart Fail; 2008 Jul; 10(7):703-8. PubMed ID: 18571471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?].
    Mehnert H
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1086-8. PubMed ID: 2500320
    [No Abstract]   [Full Text] [Related]  

  • 10. [Oral antidiabetic therapy].
    Schneider S; Pazdzierny G; Klein HH
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S264-7. PubMed ID: 17139584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is metformin safe enough for ageing type 2 diabetic patients?
    Gregorio F; Ambrosi F; Filipponi P; Manfrini S; Testa I
    Diabetes Metab; 1996 Feb; 22(1):43-50. PubMed ID: 8697295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
    Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UK Prospective Diabetes Study.
    Bailey CJ; Grant PJ
    Lancet; 1998 Dec; 352(9144):1932; author reply 1934. PubMed ID: 9863806
    [No Abstract]   [Full Text] [Related]  

  • 14. The UK Prospective Diabetes Study.
    Evans M
    Lancet; 1998 Dec; 352(9144):1932-3; author reply 1934. PubMed ID: 9863807
    [No Abstract]   [Full Text] [Related]  

  • 15. Roundtable. Blueprint for conversion of patients on metformin and sulfonylurea to Glucovance.
    Roselli A; Hayes JD; Seidner R; Marchione V; Snyder CM; Mayes K; Stiernberg CM; Milgram L
    Manag Care; 2001 Feb; 10(2 Suppl):17-21. PubMed ID: 11729404
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration.
    Kahler KH; Rajan M; Rhoads GG; Safford MM; Demissie K; Lu SE; Pogach LM
    Diabetes Care; 2007 Jul; 30(7):1689-93. PubMed ID: 17440170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
    Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
    Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
    Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
    Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Minor differences in outcome comparing early vs. later initiation of medicamentous blood glucose control in type 2 diabetic patients].
    Ritzman P
    Praxis (Bern 1994); 1999 Aug; 88(31-32):1289-90. PubMed ID: 10479970
    [No Abstract]   [Full Text] [Related]  

  • 20. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
    Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.